InvestorsHub Logo

CYRXorbust

03/13/17 6:40 PM

#10399 RE: ConstitutionNow #10398

i would not bet on it. transaction costs aren't as much a concern during clinical trials. the revenue per transaction when they go commercial will my guess go down and when insurances are picking up the tab they will certainly negotiate what they feel they should kick in

For us to get a long term secondary mkt investment from IBs, mutual funds etc the respective money managers will not only look at the potential of the company but also give a once over to our management team. i cannot say it enough.. these guys are bench players. we want big money to buy into our story and lock up a large size of the float to reduce supply. last thing we need are traders in this when we finally start moving.